Saying OrganiGram Holdings (NASDAQ: OGI) now has momentum following British American Tobacco 's (NYSE: BTI) acquisition of almost 20% of the company, a pair of analysts see the marijuana grower's market share doubling by 2026.
The increased opportunity also caused the analysts, Rahul Sarugaser and Michael W. Freeman at Raymond James (NYSE: RJF) , to double their price target for its stock to $6 per share Canadian ($4.78).
Image source: Getty Images.
For further details see:
Organigram's Market Share to Double With British American Tobacco Partnership, Analysts Say